NCT06476717View on ClinicalTrials.gov

Donor-derived Cell-free DNA in Kidney Transplant Recipients

CompletedOBSERVATIONAL
Enrollment

143

Participants

Timeline

Start Date

October 21, 2021

Primary Completion Date

May 12, 2024

Study Completion Date

May 20, 2024

Conditions
Kidney TransplantationAcute Rejection of Renal Transplant
Interventions
PROCEDURE

Biopsy

Kidney allograft biopsy

DIAGNOSTIC_TEST

Blood Biomarkers - cfDNA

dd-cfDNA

DRUG

Antirejection therapy

Patients will receive standard antirejection therapy according to center protocol.

Trial Locations (1)

140 21

Institute for Clinical and Experimental Medicine, Prague

Sponsors

Collaborators (1)

Natera, Inc.
All Listed Sponsors
collaborator

Natera, Inc.

INDUSTRY

lead

Institute for Clinical and Experimental Medicine

OTHER_GOV

NCT06476717 - Donor-derived Cell-free DNA in Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter